Effects of lifestyle interventions on rural patients with type 2 diabetes mellitus.

Body mass index Lifestyle interventions Type 2 diabetes mellitus

Journal

World journal of diabetes
ISSN: 1948-9358
Titre abrégé: World J Diabetes
Pays: United States
ID NLM: 101547524

Informations de publication

Date de publication:
15 Jun 2020
Historique:
received: 26 12 2019
revised: 30 03 2020
accepted: 05 05 2020
entrez: 18 6 2020
pubmed: 18 6 2020
medline: 18 6 2020
Statut: ppublish

Résumé

The prevalence of type 2 diabetes mellitus (T2DM) is rising rapidly in rural areas, and lifestyle interventions can effectively reduce the blood glucose levels of patients with T2DM. However, current dietary and exercise guidelines are still at experimental stages and are difficult for subjects to understand and implement. The Human Metabolism Analyzer provides real life interventions for the prevention and treatment of T2DM, and our pilot research has demonstrated its effectiveness and good compliance. To investigate the effect of and compliance with lifestyle interventions in rural patients with T2DM. A total of ten rural villages were randomly selected in Chaoshui Township, Penglai City, Shandong Province, China, to conduct health screening among residents aged 50 years or older. Each rural village represented a group, and 12 patients with T2DM were randomly selected from each group (total: 120) to participate in this study and receive real life lifestyle interventions and medication guidance. Lifestyle interventions included changing the meal order (A), postprandial activities (B), resistance exercise (C), and reverse abdominal breathing (D). Diabetes education was conducted at least once a month with a weekly phone follow-up to monitor exercise and diet. Waist circumference, blood pressure, body mass index (BMI), motor function, body composition, fasting blood glucose, and glycated hemoglobin (HbA1c) were analyzed before and 3 mo after the intervention. Moreover, patient compliance and adjustments of hypoglycemic drugs were evaluated. A total of 109 subjects completed the study. The compliance rates for lifestyle interventions A, B, C, and D were 57.79%, 60.55%, 64.22%, and 75.23%, respectively. Among the subjects who received hypoglycemic drugs, the dose was reduced 2 to 3 times based on blood glucose in 54 (67.50%) subjects and was tapered and discontinued in 5 (6.25%) subjects within 3 mo, with no significant fluctuations in blood glucose after dose reduction and withdrawal. After lifestyle interventions, waist circumference, BMI, fasting blood glucose, and HbA1c significantly decreased ( For patients with T2DM, compliance to real-life lifestyle interventions is good, and the interventions significantly improve metabolic indicators such as waist circumference, BMI, blood pressure, HbA1c, body composition, and motor function. Some patients are able to taper or discontinue hypoglycemic drugs.

Sections du résumé

BACKGROUND BACKGROUND
The prevalence of type 2 diabetes mellitus (T2DM) is rising rapidly in rural areas, and lifestyle interventions can effectively reduce the blood glucose levels of patients with T2DM. However, current dietary and exercise guidelines are still at experimental stages and are difficult for subjects to understand and implement. The Human Metabolism Analyzer provides real life interventions for the prevention and treatment of T2DM, and our pilot research has demonstrated its effectiveness and good compliance.
AIM OBJECTIVE
To investigate the effect of and compliance with lifestyle interventions in rural patients with T2DM.
METHODS METHODS
A total of ten rural villages were randomly selected in Chaoshui Township, Penglai City, Shandong Province, China, to conduct health screening among residents aged 50 years or older. Each rural village represented a group, and 12 patients with T2DM were randomly selected from each group (total: 120) to participate in this study and receive real life lifestyle interventions and medication guidance. Lifestyle interventions included changing the meal order (A), postprandial activities (B), resistance exercise (C), and reverse abdominal breathing (D). Diabetes education was conducted at least once a month with a weekly phone follow-up to monitor exercise and diet. Waist circumference, blood pressure, body mass index (BMI), motor function, body composition, fasting blood glucose, and glycated hemoglobin (HbA1c) were analyzed before and 3 mo after the intervention. Moreover, patient compliance and adjustments of hypoglycemic drugs were evaluated.
RESULTS RESULTS
A total of 109 subjects completed the study. The compliance rates for lifestyle interventions A, B, C, and D were 57.79%, 60.55%, 64.22%, and 75.23%, respectively. Among the subjects who received hypoglycemic drugs, the dose was reduced 2 to 3 times based on blood glucose in 54 (67.50%) subjects and was tapered and discontinued in 5 (6.25%) subjects within 3 mo, with no significant fluctuations in blood glucose after dose reduction and withdrawal. After lifestyle interventions, waist circumference, BMI, fasting blood glucose, and HbA1c significantly decreased (
CONCLUSION CONCLUSIONS
For patients with T2DM, compliance to real-life lifestyle interventions is good, and the interventions significantly improve metabolic indicators such as waist circumference, BMI, blood pressure, HbA1c, body composition, and motor function. Some patients are able to taper or discontinue hypoglycemic drugs.

Identifiants

pubmed: 32547700
doi: 10.4239/wjd.v11.i6.261
pmc: PMC7284015
doi:

Types de publication

Journal Article

Langues

eng

Pagination

261-268

Informations de copyright

©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors have no actual or potential conflicts of interest to declare.

Références

Diabetes Care. 2006 Nov;29(11):2518-27
pubmed: 17065697
Lancet. 2006 Nov 11;368(9548):1673-9
pubmed: 17098085
Clin Nurs Res. 2016 Feb;25(1):67-78
pubmed: 24939931
Crit Rev Food Sci Nutr. 2012;52(5):382-9
pubmed: 22369258
Diabetes Care. 1997 Apr;20(4):537-44
pubmed: 9096977
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Ann Intern Med. 2013 Oct 15;159(8):543-51
pubmed: 24126648
Metabolism. 2015 Feb;64(2):338-47
pubmed: 25467842
Lancet. 2009 Nov 14;374(9702):1677-86
pubmed: 19878986
JAMA. 2017 Jun 27;317(24):2515-2523
pubmed: 28655017
J Am Heart Assoc. 2015 Jun 26;4(7):
pubmed: 26116691
J Cardiol. 2011 Sep;58(2):173-80
pubmed: 21741799
JAMA. 2013 Sep 4;310(9):948-59
pubmed: 24002281
Diabetes Spectr. 2014 Aug;27(3):197-206
pubmed: 26246780
Nutr Rev. 2009 Feb;67(2):114-20
pubmed: 19178654
Exp Gerontol. 2013 Sep;48(9):888-97
pubmed: 23832077
Diabetes Care. 2003 May;26(5):1580-8
pubmed: 12716822
Lancet. 2008 May 24;371(9626):1783-9
pubmed: 18502303

Auteurs

Bo Wang (B)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Xiao-Li Mu (XL)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Juan Zhao (J)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Hai-Ping Jiang (HP)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Shan-Shan Li (SS)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Ge Yan (G)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Ying-Ying Hua (YY)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Xue-Yi Ren (XY)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Li-Xia Xing (LX)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Yan Liang (Y)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Shu-Dong Zhang (SD)

Department of Internal Medicine, Yantaishan Hospital, Yantai 264025, Shandong Province, China.

Yu-Chi Zhao (YC)

Department of Osteoarthropathy, Yantaishan Hospital, Yantai 264025, Shandong Province, China. zhaoyuchizyc@163.com.

Classifications MeSH